Statement: pseudomonas fluorescens/putida group is a non-taxonomic grouping of bacteria assigned to the pseudomonas genus that includes the species p. fluorescens and p. putida. Diarrhoea is the most common adverse event in the primary trial and the secondary trial.
Primary_evidence: Adverse Events 1:   Total: 17/65 (26.15%)   Febrile neutropenia 3/65 (4.62%)   Neutropenia 2/65 (3.08%)   Pancytopenia 1/65 (1.54%)   Thrombocytopenia 1/65 (1.54%)   Cardiac arrest 2/65 (3.08%)   Myocardial infarction 1/65 (1.54%)   Diarrhoea 5/65 (7.69%)   Stomatitis 1/65 (1.54%)   Vomiting 2/65 (3.08%)   Fatigue 1/65 (1.54%)   Jaundice 1/65 (1.54%)   Neutropenic infection 2/65 (3.08%)
Secondary_evidence: Adverse Events 1:   Total: 173/472 (36.65%)   Anaemia 6/472 (1.27%)   Febrile neutropenia 4/472 (0.85%)   Iron deficiency anaemia 1/472 (0.21%)   Leukopenia 2/472 (0.42%)   Neutropenia 2/472 (0.42%)   Thrombocytopenia 4/472 (0.85%)   Acute myocardial infarction 1/472 (0.21%)   Aortic valve incompetence 0/472 (0.00%)   Atrial fibrillation 2/472 (0.42%)   Cardiac arrest 1/472 (0.21%) Adverse Events 2:   Total: 40/238 (16.81%)   Anaemia 0/238 (0.00%)   Febrile neutropenia 1/238 (0.42%)   Iron deficiency anaemia 0/238 (0.00%)   Leukopenia 0/238 (0.00%)   Neutropenia 2/238 (0.84%)   Thrombocytopenia 0/238 (0.00%)   Acute myocardial infarction 0/238 (0.00%)   Aortic valve incompetence 1/238 (0.42%)   Atrial fibrillation 0/238 (0.00%)   Cardiac arrest 0/238 (0.00%)